These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3802190)

  • 1. Effects of extracellular calcium and of the calcium entry blockers flunarizine and nimodipine on contractile responses in human temporal arteries.
    Jansen I; Edvinsson L
    Cephalalgia; 1986 Dec; 6(4):235-40. PubMed ID: 3802190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.
    Jansen I; Tfelt-Hansen P; Edvinsson L
    Eur J Clin Pharmacol; 1991; 40(1):7-15. PubMed ID: 2060549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: differences related to site of origin.
    Sunman W; Martin G; Hair WM; Sever PS; Hughes AD
    J Hum Hypertens; 1993 Apr; 7(2):189-91. PubMed ID: 8389874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries.
    Brandt L; Andersson KE; Edvinsson L; Ljunggren B
    J Cereb Blood Flow Metab; 1981; 1(3):339-47. PubMed ID: 6948814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-vascular action of calcium blockers in migraine: pupillopharmacological study.
    Fanciullacci M; Pietrini U; Nicolodi M; Sicuteri F
    Funct Neurol; 1986; 1(4):533-7. PubMed ID: 3038706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular reactivity and calcium-entry blockers.
    Van Nueten JM; De Clerck F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():575-83. PubMed ID: 6233852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients.
    Nuti A; Lucetti C; Pavese N; Dell'Agnello G; Rossi G; Bonuccelli U
    Cephalalgia; 1996 Aug; 16(5):337-40. PubMed ID: 8869769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study].
    Paterna S; Martino SG; Campisi D; Cascio Ingurgio N; Marsala BA
    Clin Ter; 1990 Jul; 134(2):119-25. PubMed ID: 2147612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium channel blockers and prevention of migraine].
    Montastruc JL; Senard JM
    Pathol Biol (Paris); 1992 Apr; 40(4):381-8. PubMed ID: 1353873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of the effect of nimodipine and flunarizine on the intact and ischemic myocardium].
    Kazanova GV; Kirsanova GIu; Tsorin IB; Chichkanov GG
    Farmakol Toksikol; 1990; 53(3):13-5. PubMed ID: 2387372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimodipine, Bay K 8644 and pinacidil on alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction in human hand veins.
    Arner M; Högestätt ED; Andersson KE
    Acta Physiol Scand; 1988 Jul; 133(3):417-22. PubMed ID: 2465670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-channel blockers in the treatment of migraine.
    Gelmers HJ
    Am J Cardiol; 1985 Jan; 55(3):139B-143B. PubMed ID: 3881906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain.
    Fadda F; Gessa GL; Mosca E; Stefanini E
    J Neural Transm; 1989; 75(3):195-200. PubMed ID: 2926382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
    Nishikibe M; Fukuroda T; Nakajima A
    Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
    Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
    J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nimodipine useful in migraine prophylaxis? Further considerations.
    Leone M; Frediani F; Patruno G; Valentini S; Bussone G
    Headache; 1990 May; 30(6):363-5. PubMed ID: 2196239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of verapamil and flunarizine on epinephrine-induced vasoconstriction and on spontaneous vasomotion of arterioles in skeletal muscle in the rat in vivo.
    De Clerck F; Loots W; Voeten J; Janssen PA
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):76-83. PubMed ID: 2468939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pupillary and vascular effects of calcium antagonists in migraine.
    Fanciullacci M; Boccuni M; Pietrini U; Cangi F; Gatto G; Marabini S; Fusco BM
    Cephalalgia; 1985 May; 5 Suppl 2():181-3. PubMed ID: 4016932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.